세계의 대동맥 판막 치환술 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Aortic Valve Replacement Devices Market size is anticipated to grow from USD 7.59 Billion in 2024 to USD 18.89 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.66% during the forecast period of 2026 to 2033.

The aortic valve replacement devices market is set for substantial growth, driven by the increasing prevalence of aortic stenosis and the aging global population. As cardiovascular diseases continue to rise, the demand for effective and minimally invasive treatment options is becoming paramount. Aortic valve replacement procedures, particularly transcatheter aortic valve replacement (TAVR), are gaining traction due to their ability to provide significant clinical benefits with reduced recovery times compared to traditional surgical approaches.

Technological advancements in valve design and delivery systems are enhancing the safety and efficacy of aortic valve replacement procedures. The development of bioprosthetic valves and innovative materials is improving patient outcomes and expanding the eligibility criteria for patients who may benefit from these interventions. Additionally, the growing emphasis on patient-centered care is driving the demand for devices that offer improved durability and performance, ensuring long-term success in valve replacement.

Furthermore, the increasing awareness of cardiovascular health and the importance of early diagnosis are contributing to the growth of the aortic valve replacement devices market. As healthcare providers focus on proactive management of heart conditions, the demand for advanced diagnostic tools and treatment options is expected to rise. The integration of digital health technologies, such as remote monitoring and telemedicine, is also enhancing patient engagement and follow-up care, further supporting the market's expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• Balloon-expandable
• Self-expandable
• Mechanically Expandable
• Aortic Regurgitation

By Leaflet Material

• Bovine Pericardium
• Porcine Pericardium

By Frame Material

• Cobalt-Chromium
• Nitinol
• Others

By End-Use

• Inpatient Facilities
• Outpatient Facilities
• COMPANIES PROFILED
• Boston Scientific Corporation
• Artivion Inc
• LivaNova PLC
• Abbott
• Comp7
• Medtronic
• Edwards Lifesciences Corporation
• Cryolife Inc.
• JenavValve Technology Inc.
• Micro Interventional Devices
• Braile Biomedica
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. AORTIC VALVE REPLACEMENT DEVICES INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Leaflet Material
  • 3.7.3 Market Attractiveness Analysis By Frame Material
  • 3.7.4 Market Attractiveness Analysis By End-Use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Balloon-expandable Historic and Forecast Sales By Regions
• 5.4. Self-expandable Historic and Forecast Sales By Regions
• 5.5. Mechanically Expandable Historic and Forecast Sales By Regions
• 5.6. Aortic Regurgitation Historic and Forecast Sales By Regions

6. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET ANALYSIS BY LEAFLET MATERIAL

• 6.1. Overview By Leaflet Material
• 6.2. Historical and Forecast Data Analysis By Leaflet Material
• 6.3. Bovine Pericardium Historic and Forecast Sales By Regions
• 6.4. Porcine Pericardium Historic and Forecast Sales By Regions

7. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET ANALYSIS BY FRAME MATERIAL

• 7.1. Overview By Frame Material
• 7.2. Historical and Forecast Data Analysis By Frame Material
• 7.3. Cobalt-Chromium Historic and Forecast Sales By Regions
• 7.4. Nitinol Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-Use
• 8.2. Historical and Forecast Data Analysis By End-Use
• 8.3. Inpatient Facilities Historic and Forecast Sales By Regions
• 8.4. Outpatient Facilities Historic and Forecast Sales By Regions

9. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AORTIC VALVE REPLACEMENT DEVICES COMPANIES

• 10.1. Aortic Valve Replacement Devices Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF AORTIC VALVE REPLACEMENT DEVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Boston Scientific Corporation
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Artivion Inc
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. LivaNova PLC
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Abbott
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Comp7
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Medtronic
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Edwards Lifesciences Corporation
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Cryolife Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. JenavValve Technology Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Micro Interventional Devices
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Braile Biomedica
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies